Area:
Somatosensation and Thermoregulation
We are testing a new system for linking grants to scientists.
The funding information displayed below comes from the
NIH Research Portfolio Online Reporting Tools and the
NSF Award Database.
The grant data on this page is limited to grants awarded in the United States and is thus partial. It can nonetheless be used to understand how funding patterns influence mentorship networks and vice-versa, which has deep implications on how research is done.
You can help! If you notice any innacuracies, please
sign in and mark grants as correct or incorrect matches.
Sign in to see low-probability grants and correct any errors in linkage between grants and researchers.
High-probability grants
According to our matching algorithm, Jena B. Goodman is the likely recipient of the following grants.
Years |
Recipients |
Code |
Title / Keywords |
Matching score |
2018 — 2020 |
Goodman, Jena Brooke |
F31Activity Code Description: To provide predoctoral individuals with supervised research training in specified health and health-related areas leading toward the research degree (e.g., Ph.D.). |
Role of Serca2 C674 Oxidation in Mediating Apoptosis in Cardiac Myocytes @ Boston University Medical Campus
Project Summary: Heart failure is a debilitating condition in which the heart cannot meet the metabolic demands of the body. Chronic ?-adrenergic (?-AR) stimulation causes pathological myocardial remodeling that leads to heart failure. Chronic ?-AR stimulation contributes to myocardial remodeling by promoting apoptosis of cardiac myocytes. Work from our laboratory has shown that ?-AR stimulated apoptosis is dependent on reactive oxygen species (ROS), but the molecular target(s) by which ROS mediates apoptosis is not known. We have also shown that sarcoplasmic reticulum calcium ATPase (SERCA2), a key regulator of cardiac myocyte calcium, can undergo oxidative post-translational modification (OPTM) of cysteine C674: High levels of ROS inhibit SERCA2 activity through irreversible OPTM of SERCA2 C674. SERCA2 is responsible for moving the large majority of intracellular calcium in the cardiac myocyte, and may thereby affect the level of calcium in mitochondria, where excessive calcium activates the intrinsic mitochondrial apoptosis pathway. We hypothesize that oxidative inhibition of SERCA2 at C674 increases mitochondrial calcium, thereby activating the mitochondrial apoptosis pathway. To address this thesis, we will use of a novel redox-insensitive SERCA2 mutation in which C674 is replaced by serine (C674S) to determine the role of oxidative inhibition in ?-AR stimulated apoptosis both in vitro in cardiac myocytes and in vivo in mice. We will elucidate the role of SERCA2 oxidative inhibition in vitro by assessing ?-AR stimulated apoptosis in adult rat ventricular myocytes (ARVM) that overexpress wild type or C674S SERCA2. To identify whether oxidative inhibition of SERCA2 at C674 affects mitochondrial calcium we have created ultrasensitive genetically-encoded calcium indicators (GECI) targeted to the mitochondria, mitochondrial-associated membrane (MAM) and cytosol which will be expressed in ARVM via adenovirus infection. These novel GECI will allow us to measure calcium levels in the mitochondria and MAMs, and assess the relationship to apoptosis. To test our hypothesis in vivo, we will generate a cardiac myocyte-specific redox- insensitive SERCA2 mouse in which there is knock-in of the C674S mutant. With this mouse we will assess the role of C674 oxidation in mediating pathological remodeling in response to a chronic ?-AR challenge at the cellular and organ levels. Taken together, these experiments will elucidate the role of SERCA2 oxidation in mediating apoptosis in cardiac myocytes, thereby identifying a novel mechanism contributing to heart failure.
|
0.97 |